Wei Lai

Dr. Wei Lai


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
YZYue Zheng
Yue Zheng
WLWei Lai
Wei Lai
In December, 2019, a series of pneumonia cases in Wuhan, China, was caused by a novel coronavirus (Covid‐19) [1‐2], has become a global health concern [3]. At present the epidemic in China has been well controlled, but Covid‐19 are currently spreading in many other countries all over the world. Dermatologists in China have participated in the fight against Covid‐19. In this paper we share our experiences in dealing with skin diseases in this special period and hope to provide some references for international colleagues in the epidemic situation.

21 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
QXQingfang Xu
Qingfang Xu
WHWei Hou
Wei Hou
YZYue Zheng
Yue Zheng
CLChen Liu
Chen Liu
ZGZijian Gong
Zijian Gong
HMHoward I. Maibach
Howard I. Maibach
Cathepsin K (CatK), a cysteine protease with the potent elastolytic activity, plays a predominant role in intracellular elastin degradation in human dermal fibroblasts (HDFs), and contributes to solar elastosis. In previous studies, CatK expression was downregulated in photoaged skin and fibroblasts, but upregulated in acute UVA-irradiated skin and fibroblasts. The underlying mechanisms regulating UVA-induced CatK expression remain elusive. This study investigates mechanisms involved in the regulation of UVA-induced CatK expression in HDFs. Primary HDFs were exposed to UVA. Cell proliferation was analyzed using a colorimetric assay of relative cell number. Quantitative real-time RT-PCR and Western blot were performed to detect CatK expression in HDFs on three consecutive days after 10 J/cm2 UVA irradiation, or cells treated with increasing UVA doses. UVA-activated MAPK/AP-1 pathway was examined by Western blot. Effects of inhibition of MAPK pathway and knockdown of Jun and Fos on UVA-induced CatK expression were also measured by real-time RT-PCR and Western blot. UVA significantly increased CatK mRNA and protein expression in a dose-dependent manner. UVA-induced CatK expression occurred along with UVA-activated phosphorylation of JNK, p38 and Jun, UVA-increased expression of Fos. Inactivation of JNK and p38MAPK pathways both remarkably decreased UVA-induced CatK expression, which was suppressed more by inhibition of JNK pathway. Furthermore, knockdown of Jun and Fos significantly attenuated basal and UVA-induced CatK expression. UVA is capable of increasing CatK expression in HDFs, most likely by activation of MAPK pathway and of AP-1, which has been shown to be the case for matrix metalloproteinases. As current strategies for selecting anti-photoaging agents focus on their ability to decrease MMPs' expression through inhibiting UV- activated MAPK pathway, future strategies should also consider their effect on CatK expression.

29 December 2014 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MWMiao‐Jian Wan
Miao‐Jian Wan
XSXiang‐Yang Su
Xiang‐Yang Su
YZYue Zheng
Yue Zheng
ZGZi‐Jian Gong
Zi‐Jian Gong
JYJin‐Ling Yi
Jin‐Ling Yi
WLWei Lai
Wei Lai

4 August 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
LZLiming Zhang
Liming Zhang
LQLi Qiu
Li Qiu
JWJian Wu
Jian Wu
YQYumeng Qi
Yumeng Qi
XGXinghua Gao
Xinghua Gao
TXTing Xiao
Ting Xiao

1 April 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
ZGZijian Gong
Zijian Gong
WLWei Lai
Wei Lai
MLMin Liu
Min Liu
ZHZhengshuang Hua
Zhengshuang Hua
YSYayin Sun
Yayin Sun
XXXiaoyuan Xie
Xiaoyuan Xie
The emergence of ceftriaxone-resistant Neisseria gonorrhoeae is currently a global public health concern. However, the mechanism of ceftriaxone resistance is not yet fully understood. To investigate the potential genes related to ceftriaxone resistance in Neisseria gonorrhoeae , we subcultured six gonococcal strains with increasing concentrations of ceftriaxone and isolated the strains that became resistant. After analyzing several frequently reported genes involved in ceftriaxone resistance, we found only a single mutation in penA (A501V). However, differential analysis of the genomes and transcriptomes between pre- and postselection strains revealed many other mutated genes as well as up- and downregulated genes. Transformation of the mutated penA gene into nonresistant strains increased the MIC between 2.0- and 5.3-fold, and transformation of mutated ftsX increased the MIC between 3.3- and 13.3-fold. Genes encoding the ABC transporters FarB, Tfq, Hfq, and ExbB were overexpressed, while pilM , pilN , and pilQ were downregulated. Furthermore, the resistant strain developed cross-resistance to penicillin and cefuroxime, had an increased biochemical metabolic rate, and presented fitness defects such as prolonged growth time and downregulated PilMNQ. In conclusion, antimicrobial pressure could result in the emergence of ceftriaxone resistance, and the evolution of resistance of Neisseria gonorrhoeae to ceftriaxone is a complicated process at both the pretranscriptional and posttranscriptional levels, involving several resistance mechanisms of increased efflux and decreased entry.

21 October 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
CYCongxiu Ye
Congxiu Ye
YZYunqing Zhang
Yunqing Zhang
ZSZhen Su
Zhen Su
SWShuxia Wu
Shuxia Wu
YLYuxia Li
Yuxia Li
YZYue Zheng
Yue Zheng
Background: Recent studies have reported that the incidence of sensitive skin is increasing. Skin sensitivity and skin barrier functions were related to many skin diseases including atopic dermatitis, psoriasis, rosacea, and so on. Mesenchymal stem cell (MSC)-derived exosomes (hMSC) might be considered as a new effective therapeutic scheme.Aims: This study aims to investigate the safety and efficacy of hMSC exosomes as a novel topical treatment for sensitive skin.Patients/Methods: Exosomes were extracted from primary hMSC via ultracentrifugation method. The morphology of hMSC exosomes was studied via transmission electron microscope. Expression of exosome specific surface marker was detected via Western blot. 22 subjects (female, aged 18–55) diagnosed with sensitive skin were enrolled. Follow-up was conducted before, 7-day, 14-day, and 28-day after hMSC exosomes use. Transepidermal water loss (TEWL), surface hydration, sebum secretion, and L*a*b* value were simultaneously tested at the same time point in an environment-controlled room.Results: Under transmission electron microscopy, the extracted hMSC exosomes were circular or elliptical with intact membrane structure, and their diameters ranged mainly from 40 to 80 nm. Western blot showed that the expression of markers CD63, CD9, and Tsg101 was positive. Brownian motion based nanoparticle trajectory analysis (NTA) showed that the main peak of particle size distribution occurred around 96 nm, the average particle size was 122 nm, and the main peak accounted for 96.7%. All this conformed to the biological characteristics of exosomes standardized by the International Society for Extracellular Vesicles. In the clinical trial, scores of objective symptoms including roughness, scales, erythema, and subjective symptoms including tension, burning, or itching, were improved after 7-, 14-, and 28- day using hMSC-exosomes. TEWL, hydration, sebum, pH, and a* values were tended to return to the level of healthy skin.Conclusion: The hMSC-exosomes, with the advantages of biocompatibility and biodegradability, could improve clinical symptoms and eruptions in sensitive skin patients, and might be as an MSC cell-free novel therapy in sensitive skin-related disease treatment.